Literature DB >> 23400684

Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues.

Susan Y Ritter1, Roopashree Subbaiah, Gurkan Bebek, James Crish, Carla R Scanzello, Bryan Krastins, David Sarracino, Mary F Lopez, Mary K Crow, Thomas Aigner, Mary B Goldring, Steven R Goldring, David M Lee, Reuben Gobezie, Antonios O Aliprantis.   

Abstract

OBJECTIVE: The pathophysiology of the most common joint disease, osteoarthritis (OA), remains poorly understood. Since synovial fluid (SF) bathes joint cartilage and synovium, we reasoned that a comparative analysis of its protein constituents in health and OA could identify pathways involved in joint damage. We undertook this study to perform a proteomic analysis of knee SF from OA patients and control subjects and to compare the results to microarray expression data from cartilage and synovium.
METHODS: Age-matched knee SF samples from 10 control subjects, 10 patients with early-stage OA, and 10 patients with late-stage OA were compared using 2-dimensional difference-in-gel electrophoresis and mass spectrometry (MS). MS with a multiplexed peptide selected reaction monitoring assay was used to confirm differential expression of a subset of proteins in an independent OA patient cohort. Proteomic results were analyzed by Ingenuity Pathways Analysis and compared to published synovial tissue and cartilage messenger RNA profiles.
RESULTS: Sixty-six proteins were differentially present in healthy and OA SF. Three major pathways were identified among these proteins: the acute-phase response signaling pathway, the complement pathway, and the coagulation pathway. Differential expression of 5 proteins was confirmed by selected reaction monitoring assay. A focused analysis of transcripts corresponding to the differentially present proteins indicated that both synovial and cartilage tissues may contribute to the OA SF proteome.
CONCLUSION: Proteins involved in the acute-phase response signaling pathway, the complement pathway, and the coagulation pathway are differentially regulated in SF from OA patients, suggesting that they contribute to joint damage. Validation of these pathways and their utility as biomarkers or therapeutic targets in OA is warranted.
Copyright © 2013 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23400684      PMCID: PMC3618606          DOI: 10.1002/art.37823

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  47 in total

Review 1.  Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets.

Authors:  J P Pelletier; J Martel-Pelletier; S B Abramson
Journal:  Arthritis Rheum       Date:  2001-06

Review 2.  The development of the DIGE system: 2D fluorescence difference gel analysis technology.

Authors:  Rita Marouga; Stephen David; Edward Hawkins
Journal:  Anal Bioanal Chem       Date:  2005-05-18       Impact factor: 4.142

3.  Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins.

Authors:  Leigh Anderson; Christie L Hunter
Journal:  Mol Cell Proteomics       Date:  2005-12-06       Impact factor: 5.911

4.  Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis.

Authors:  A D Pearle; C R Scanzello; S George; L A Mandl; E F DiCarlo; M Peterson; T P Sculco; M K Crow
Journal:  Osteoarthritis Cartilage       Date:  2006-12-05       Impact factor: 6.576

Review 5.  The long-term consequence of anterior cruciate ligament and meniscus injuries: osteoarthritis.

Authors:  L Stefan Lohmander; P Martin Englund; Ludvig L Dahl; Ewa M Roos
Journal:  Am J Sports Med       Date:  2007-08-29       Impact factor: 6.202

6.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

7.  Profiling of endogenous peptides in human synovial fluid by NanoLC-MS: method validation and peptide identification.

Authors:  Jurre J Kamphorst; Rob van der Heijden; Jeroen DeGroot; Floris P J G Lafeber; Theo H Reijmers; Benno van El; Ubbo R Tjaden; Jan van der Greef; Thomas Hankemeier
Journal:  J Proteome Res       Date:  2007-10-11       Impact factor: 4.466

8.  Proteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunction.

Authors:  Elizabeth Yohannes; Jinsook Chang; George J Christ; Kelvin P Davies; Mark R Chance
Journal:  Mol Cell Proteomics       Date:  2008-03-12       Impact factor: 5.911

9.  Comparative proteomic characterization of articular cartilage tissue from normal donors and patients with osteoarthritis.

Authors:  Jiang Wu; Wei Liu; Amanda Bemis; Eunice Wang; Yongchang Qiu; Elisabeth A Morris; Carl R Flannery; Zhiyong Yang
Journal:  Arthritis Rheum       Date:  2007-11

10.  High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis.

Authors:  Reuben Gobezie; Alvin Kho; Bryan Krastins; David A Sarracino; Thomas S Thornhill; Michael Chase; Peter J Millett; David M Lee
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  63 in total

1.  Profibrotic Infrapatellar Fat Pad Remodeling Without M1 Macrophage Polarization Precedes Knee Osteoarthritis in Mice With Diet-Induced Obesity.

Authors:  Erika Barboza; Joanna Hudson; Wan-Pin Chang; Susan Kovats; Rheal A Towner; Robert Silasi-Mansat; Florea Lupu; Collin Kent; Timothy M Griffin
Journal:  Arthritis Rheumatol       Date:  2017-04-28       Impact factor: 10.995

Review 2.  Immune modulation to improve tissue engineering outcomes for cartilage repair in the osteoarthritic joint.

Authors:  Niamh Fahy; Eric Farrell; Thomas Ritter; Aideen E Ryan; J Mary Murphy
Journal:  Tissue Eng Part B Rev       Date:  2014-08-04       Impact factor: 6.389

3.  Duration of symptoms prior to partial meniscectomy is not associated with the expression of osteoarthritis genes in the injured meniscus.

Authors:  Robert H Brophy; Eric J Schmidt; Lei Cai; Muhammad Farooq Rai
Journal:  J Orthop Res       Date:  2020-01-13       Impact factor: 3.494

Review 4.  Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use.

Authors:  V B Kraus; F J Blanco; M Englund; M A Karsdal; L S Lohmander
Journal:  Osteoarthritis Cartilage       Date:  2015-04-09       Impact factor: 6.576

Review 5.  Application of Metabolomics to Osteoarthritis: from Basic Science to the Clinical Approach.

Authors:  Salah Ali A Showiheen; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Yin Xiao; R Mark Wellard; Indira Prasadam
Journal:  Curr Rheumatol Rep       Date:  2019-05-06       Impact factor: 4.592

Review 6.  The Multifunctional Role of the Chemokine System in Arthritogenic Processes.

Authors:  Giovanni Bernardini; Giorgia Benigni; Rossana Scrivo; Guido Valesini; Angela Santoni
Journal:  Curr Rheumatol Rep       Date:  2017-03       Impact factor: 4.592

7.  The change of synovial fluid proteome in rabbit surgery-induced model of knee osteoarthritis.

Authors:  Qinglu Luo; Xi Qin; Yaxian Qiu; Lingying Hou; Ning Yang
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

8.  Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus.

Authors:  Michael K Parente; Ramona Rozen; Steven H Seeholzer; John H Wolfe
Journal:  Mol Genet Metab       Date:  2016-03-07       Impact factor: 4.797

Review 9.  Emerging targets in osteoarthritis therapy.

Authors:  Mary B Goldring; Francis Berenbaum
Journal:  Curr Opin Pharmacol       Date:  2015-04-10       Impact factor: 5.547

Review 10.  Does lipopolysaccharide-mediated inflammation have a role in OA?

Authors:  Zeyu Huang; Virginia Byers Kraus
Journal:  Nat Rev Rheumatol       Date:  2015-12-10       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.